[Re: https://www.hifa.org/dgroups-rss/spotlight-group-b-strep-16-forum-questi... ]
Thank you, Claire, for your insight on these issues in LMIC settings. What can you or others in this forum suggest as first steps to these screening/diagnostic and treatment tools becoming available in LMICs? Are there any LIMCs where such progress has been made?
Even in high-income countries, there is much room for improvement in determining the cause of stillbirths. I attended one of the IMPROVE workshops years ago and found it to be fascinating even as a parent for the compassionate investigative skills in their approach. https://www.stillbirthcre.org.au/researchers-clinicians/education-and-wo...
Best,
Marti
CHIFA profile: Marti Perhach is CEO/Cofounder of Group B Strep International, United States. Professional interests: Group B strep disease research and prevention, prenatal infection, One Health. Email address: marti.perhach AT gbs-intl.org